Cargando…

Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

This article gives a comprehensive overview of cytokine and other inflammation associated protein levels in plasma, serum and cerebrospinal fluid (CSF) of patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI). We reviewed 118 research articles published between 1989 and 2013 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brosseron, Frederic, Krauthausen, Marius, Kummer, Markus, Heneka, Michael T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182618/ https://www.ncbi.nlm.nih.gov/pubmed/24567119 http://dx.doi.org/10.1007/s12035-014-8657-1

Ejemplares similares

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
por: Chalermpalanupap, Termpanit, et al.
Publicado: (2013)

Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease
por: Brosseron, Frederic, et al.
Publicado: (2018)

Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines
por: Ott, Brian R., et al.
Publicado: (2018)

PPARs in Alzheimer's Disease
por: Kummer, Markus P., et al.
Publicado: (2008)

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease
por: de la Monte, Suzanne M., et al.
Publicado: (2023)

Proteome profiling of s-nitrosylated synaptosomal proteins by isobaric mass tags
por: Wijasa, Teodora Stella, et al.
Publicado: (2017)

Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease
por: Hamilton, Calum A., et al.
Publicado: (2021)

Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment
por: Bainbridge, Wilma A., et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

Urinary Cytokines as Potential Biomarkers of Mild Cognitive Impairment and Alzheimer’s Disease: A Pilot Study
por: Saiyed, Nazia, et al.
Publicado: (2023)

Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients
por: Le Page, Aurélie, et al.
Publicado: (2017)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

CNS-Targeted Production of IL-17A Induces Glial Activation, Microvascular Pathology and Enhances the Neuroinflammatory Response to Systemic Endotoxemia
por: Zimmermann, Julian, et al.
Publicado: (2013)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
por: Hayashi, Atsuko, et al.
Publicado: (2015)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

Comparing Cognitive Profiles of Licensed Drivers with Mild Alzheimer's Disease and Mild Dementia with Lewy Bodies
por: Yamin, Stephanie, et al.
Publicado: (2016)

Detection and Prediction of Mild Cognitive Impairment in Alzheimer’s Disease Mice
por: Rai, Surya Prakash, et al.
Publicado: (2020)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
por: Capucho, Patrícia Helena Figueirêdo Vale, et al.
Publicado: (2011)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Impact and Therapeutic Potential of PPARs in Alzheimer's Disease
por: Heneka, Michael T, et al.
Publicado: (2011)

CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system
por: Krauthausen, Marius, et al.
Publicado: (2014)

Cognitive profile in mild cognitive impairment with Lewy bodies
por: Liu, Shuai, et al.
Publicado: (2022)

Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
por: Bălașa, Adrian Florian, et al.
Publicado: (2020)

Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
por: Giau, Vo Van, et al.
Publicado: (2019)

Acupuncture for Mild Cognitive Impairment and Dementia: An Overview of Systematic Reviews
por: He, Wenbo, et al.
Publicado: (2021)

A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
por: Vinceti, Marco, et al.
Publicado: (2017)

Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease
por: Ashraf, Azhaar, et al.
Publicado: (2019)

Automatic morphometry in Alzheimer's disease and mild cognitive impairment()()
por: Heckemann, Rolf A., et al.
Publicado: (2011)

Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013)

Anosognosia and Anosodiaphoria in Mild Cognitive Impairment and Alzheimer's Disease
por: Lindau, Maria, et al.
Publicado: (2014)

Prospective memory in Alzheimer’s disease and Mild Cognitive Impairment
por: Spíndola, Lívia, et al.
Publicado: (2011)

Assessment for apraxia in mild cognitive impairment and Alzheimer's dise
por: Ward, Mirela, et al.
Publicado: (2015)

Peripheral reaching in Alzheimer's disease and mild cognitive impairment
por: Mitchell, Alexandra G., et al.
Publicado: (2022)

Olfactory memory in mild cognitive impairment and Alzheimer’s disease
por: Audronyte, Egle, et al.
Publicado: (2023)

Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer’s Disease
por: Liu-Seifert, Hong, et al.
Publicado: (2015)

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
por: Kaiser, Elmar, et al.
Publicado: (2011)

Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer’s disease and mild cognitive impairment
por: Poulsen, Keld, et al.
Publicado: (2014)

Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia
por: van Wijk, Nick, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6adi0tc73cknlosf1rabeo30mc